Medicine is advancing at breakneck speed, with once-unthinkable treatments and technologies now becoming reality. These ...
Former Sen. Ben Sasse is fighting pancreatic cancer with a drug developed with a profit motive for private and university ...
Many families have been affected by serious or chronic illness. Whether it is a parent confronting a cancer diagnosis, a grandparent losing ground to Alzheimer’s, a child learning to manage juvenile ...
Clinical trials in Arizona advance medical breakthroughs, and recent successes in cancer research show the potential for faster treatments and broad impacts.
ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...
Add Yahoo as a preferred source to see more of our stories on Google. From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer's disease, 2025 has been a year ...
A new experimental drug for pancreatic cancer, daraxonrasib, appears to have extended the lives of some patients with advanced disease by several months, according to clinical trial results out last ...
A conversation with Gina Kolata, who covers breakthroughs in medical science. By Terence McGinley Times Insider explains who we are and what we do, and delivers behind-the-scenes insights into how our ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
Should you invest in the ALPS Medical Breakthroughs ETF (SBIO)?
If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the ALPS Medical Breakthroughs ETF (SBIO), a passively managed exchange traded fund ...
Medical innovation is blooming in 2024, and it has the potential to positively impact many patients. The end of 2023 brought the first FDA treatment using groundbreaking CRISPR gene editing technology ...
Medicine is entering a new era of breakthrough science, with innovations once considered out of reach now becoming reality. Researchers are developing therapies that target diseases in entirely new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results